Glucagon pre-filled pen
Treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.
CCG (HRG included)
Prescribing of Ogluo devices should be reserved for patients for whom the preparation and administration of conventional glucagon kits presents a barrier to effective treatment of hypoglycaemia and a risk to patient welfare.
Reason for decision:
Suitable for initiation in primary care in line with restrictions